Related Experiment Video

Updated: Jul 4, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

805

Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation

Zena Saleh1, Matthew C Moccia1, Zachary Ladd1

  • 1Department of Surgery, Cooper University Health Care, Camden, NJ 08103, USA.

International Journal of Molecular Sciences
|January 27, 2024
PubMed

Insights

Epigenetic alterations in pancreatic neuroendocrine tumors (PNETs) are understudied. This review explores PNET signaling pathways and their epigenetic regulation, offering insights for future drug development and patient care.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Pancreatic neuroendocrine tumors (PNETs) exhibit dysregulated signaling pathways critical for tumor growth.
  • Current therapies for advanced PNETs have limited efficacy.
  • Epigenetic modifications significantly influence cancer signaling pathways, presenting therapeutic targets.

Purpose of the Study:

  • To summarize key signaling pathways in PNET development.
  • To review the epigenetic regulation of these pathways in PNETs and other cancers.
  • To propose future research directions for the PNET epigenome and its clinical applications.

Main Methods:

  • Literature review and synthesis of existing research on PNET signaling and epigenetics.
  • Comparative analysis of epigenetic mechanisms in PNETs and other malignancies.
  • Exploration of potential therapeutic strategies based on epigenetic targets.

Main Results:

  • Identification of critical signaling pathways implicated in PNET pathogenesis.
  • Overview of the role of epigenetic alterations in modulating these pathways.
  • Highlighting the scarcity of PNET-specific epigenetic research.

Conclusions:

  • Epigenetic dysregulation is a key factor in PNET development and progression.
  • Further research into the PNET epigenome is essential for novel therapeutic strategies.
  • Understanding epigenetic modifications may lead to improved patient care and treatment outcomes for PNETs.
Keywords:
epigenetic regulationpancreatic neuroendocrine tumorssignaling pathways

More Related Videos

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

336
In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model08:23

In Vitro Modeling of Cancerous Neural Invasion: The Dorsal Root Ganglion Model

Published on: April 12, 2016

9.2K

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K